Skip to main content
22 November 2024
Last updated:
Monday 18 November 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Symphogen sees opportunities in antibody mixtures
Read more
Capital efficiency -- a new norm
Read more
A small molecule approach to inflammation: Chroma Therapeutics targets the macrophage
Read more
Securing Europe's lead in vaccine research
Read more
Review of oncology in 2010
Read more
2011: A year of optimism and trepidation
Read more
ArGEN-X builds a new antibody business
Read more
Proposed UK 'patent box' unveiled
Read more
EMA guidance on biosimilar monoclonal antibodies
Read more
Launch of Takeda Ventures
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
67
Page
68
Page
69
Page
70
Current page
71
Page
72
Page
73
Page
74
Page
75
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
